Back

Incremental value of ADMA beyond classical risk factors for cardiometabolic risk prediction in ischemic heart disease

29 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Clinico-metabolic phenotyping and heart disease (2) Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Sherzod Akhmedov

Cardiology Center of Uzbekistan, Tashkent (Uzbekistan)

6 More presentations in this session

Presentation thumbnail
Clinico-metabolic phenotyping predicts long-term mortality in at-risk and pre-clinical heart failure: a machine learning analysis
Miss A. Mavromanoli (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Understanding and predicting CVD in Singapore: socioeconomic determinants and a non-lab risk score across two cohorts
Professor D. Hausenloy (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Prediction and cumulative incidence of in-hospital bleeding among acutely ill medical patients receiving pharmacologic VTE prophylaxis based on the IMPROVE-BRS: a retrospective single-center cohort
Doctor J. Catangui (Manila, PH)
Abstract Slides Video
Presentation thumbnail
Primary care detection reveals substantial cumulative LDL-C exposure in underrecognized heterozygous FH
Doctor H. Leskaroska (Skopje, MK)
Abstract Slides Video
Presentation thumbnail
The clinical value of estimated small dense LDL in primary and secondary prevention
Doctor D. Delialis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Clinico-metabolic phenotyping and heart disease (2)

The Event

Event poster

ESC Congress 2026

29 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Associations between glucolipid metabolic indices with the risk and progression of cardiovascular-kidney-metabolic syndrome in MASLD: evidence from the UK biobank
31 August 2026
thumbnail
Congress Presentation
Bio-ADM as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure; data from STRONG-HF
14 May 2024
thumbnail
Congress Presentation
Exploring trimethylamine n-oxide's role in coronary microvascular dysfunction and prognostic outcomes in ST-elevation myocardial infarction patients
30 August 2024
thumbnail
Congress Presentation
Visualizing subclinical biomarkers of endothelial dysfunction associated with cardiovascular risk using oxygenation-sensitive cardiovascular magnetic resonance
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources